期刊文献+

国产药物洗脱支架在冠心病中的临床应用

The Clinical Application of Drug Eluting Stents Firebird(Firebird DES) in Patients with Coronary Disease
下载PDF
导出
摘要 目的评价国产药物洗脱支架(Firebird)临床应用的安全性和有效性。方法30例冠心病患者予置入Firebird支架治疗,术后对患者进行随访,观察有无胸痛复发,心电图异常改变,重要心脏不良事件等。结果30例患者共置入Firebird支架45枚,手术即刻成功率100%。对患者至少3个月随访,平均随访8个月,无重要心脏不良事件发生,1例胸痛复发,予冠脉搭桥治疗。结论Firebird支架置入即刻成功率高,治疗冠心病安全、有效。 Objective To evaluate file safety and efficeacy of Firebird DES in treatment of coronary artery disease. Melhods From July 2004 to May 2005, 30 patients underwent coronary artery s-tenting with Firebird DES. Clinical follow- up was condueted in all these patients for major adverse cardiac events such as angina pectofis, myocardia infarction, sudden death and revaseularization. Results 45 Firebird DES were implanted to 37 coronary artery lesions in all these patients. The irranediate procedure success rate of stent implation was 100%. All patients were follow up at least 3 months. There were no major adverse cardiac events except for reoccurrence of angina pectofis in one patient who received treatment of CABG later. Conclusions Short - term clinical follow - up shows Firebird DES is safe and effective in treatment of coronary artery disease.
机构地区 绍兴二院心内科
出处 《心脑血管病防治》 2006年第1期3-4,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 冠心病 药物洗脱支架 冠脉造影 FIREBIRD Firebird Coronary artery disease Drug eluting stents
  • 相关文献

参考文献5

  • 1Serruys PW. ARTS Ⅰ - the rapamycine eluting stent; ARTS Ⅱ - the rosy prophecy. Eur Heart J, 2002, 23:757 -759.
  • 2Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J MedED, 2002, 346:1773 - 1780.
  • 3Schofer J, Schluter M, Gershlick AH, et al. Sirolimus eluting for treatment of patients with long athemsclerotic lesions in srall coronary arteries: double blind, rundomized controller trial (E SIRJUS). Lancet, 2003, 362:1093 - 1099.
  • 4倪钧,沈卫峰,张建盛,胡健,张奇,张宪,郑爱芳.Firebird药物洗脱支架治疗冠状动脉原发病变[J].介入放射学杂志,2004,13(5):396-398. 被引量:37
  • 5魏盟,马士新,陆志刚,蒋利,杭靖宇,张洁,李京波,顾水明,张昀昀,金立仁.冠心病患者应用紫杉醇与国产雷帕霉素洗脱支架的随机对照研究[J].中国循环杂志,2005,20(2):90-93. 被引量:16

二级参考文献15

  • 1Serruys PW. ARTS I - the rapamycin eluting stent; ARTS II - the rosy prophecy. Eur Heart J, 2002, 23: 757-759.
  • 2Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323.
  • 3Ruygrok PN, Muller DW, Serruys PW. Rapamycin in cardiovascular medicine. Intern Med J, 2003, 33:103-109.
  • 4Lemos PA, Lee CH, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am Coll Cardiol, 2003, 41:2093-2099.
  • 5Morice MC, Serruys PW, Sausa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary Med, 2002, 346:1773-1780.
  • 6Moses JW, Leon MB, Popma JJ, et al. Sirolimus-Eluting Stents versus revascularization. N Engl J Standard Stents in Patients with Stenosis in a Native Coronary Artery. N Engl J Med, 2003, 349:1315-1323.
  • 7Gensini GG. Amore meaningful scoring system for determing the severity of coronary heart disease.Am J Cardiol,1983,51:606.
  • 8Stone GW, Ellis SG, Cox DA, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med, 2003,350:221-231.
  • 9Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow-and moderate-release, polymer-based, paclitaxel-eluting stents for coronary artery lesions. Circulation, 2003,108:788-794.
  • 10Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over 6 months. J Am Coll Cardiol, 2000,36:2325-2332.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部